Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Preisser

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
Cancers|February 15, 2022
Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair AnalysisDerya Tilki, Felix Preisser, Reinhard Thamm, et al.
Urologic Oncology|October 9, 2025
Use of staging in intermediate-risk prostate cancer: A real-world data analysisBen Frederik Hartwieg, Tobias Maurer, Christopher Kniep, et al.
The Prostate|September 26, 2019
Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancerFelix Preisser, Gilberto Coxilha, Alexander Heinze, et al.
Frontiers in Oncology|February 19, 2025
The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancerCarolin Siech, Mike Wenzel, Georgina Knoblich, et al.
Urologia Internationalis|September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated PatientsMike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancerFelix Preisser, Giorgio Gandaglia, Farid Arad, et al.
World Journal of Urology|March 2, 2018
Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRIRaisa S Pompe, Bieke Kühn-Thomä, Yamini Nagaraj, et al.
World Journal of Urology|May 3, 2018
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancerMarco Bandini, Michele Marchioni, Felix Preisser, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
Cancers|February 15, 2022
Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair AnalysisDerya Tilki, Felix Preisser, Reinhard Thamm, et al.
Urologic Oncology|October 9, 2025
Use of staging in intermediate-risk prostate cancer: A real-world data analysisBen Frederik Hartwieg, Tobias Maurer, Christopher Kniep, et al.
The Prostate|September 26, 2019
Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancerFelix Preisser, Gilberto Coxilha, Alexander Heinze, et al.
Frontiers in Oncology|February 19, 2025
The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancerCarolin Siech, Mike Wenzel, Georgina Knoblich, et al.
Urologia Internationalis|September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated PatientsMike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancerFelix Preisser, Giorgio Gandaglia, Farid Arad, et al.
World Journal of Urology|March 2, 2018
Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRIRaisa S Pompe, Bieke Kühn-Thomä, Yamini Nagaraj, et al.
World Journal of Urology|May 3, 2018
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancerMarco Bandini, Michele Marchioni, Felix Preisser, et al.
Pageof 17